Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

07.08.08	King Pharmaceuticals Reports Second-Quarter 2008 Financial Results (Businesswire)
30.06.08	FDA Approves First and Only Single-Dose Antibiotic for Dogs and Cats (Businesswire)
10.06.08	Bristol-Myers Squibb and Pfizer Initiate New Study in the Apixaban Phase 3 Clinical Trial Program (Businesswire)
02.06.08	Pfizer Reviews Progress of Oncology Pipeline and New Commercial Business Unit Structure with Analysts (Businesswire)
02.06.08	Updated CDX-110 Data in Glioblastoma Multiforme Presented at 44th Annual ASCO Annual Meeting (Businesswire)
21.05.08	New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients (Businesswire)
21.05.08	AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer (PR Newswire)
08.05.08	King Pharmaceuticals Reports First-Quarter 2008 Financial Results (Businesswire)
01.04.08	Pfizer Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma (Businesswire)
27.03.08	Pfizer Clears U.S. Antitrust Review for Acquisition of All Outstanding Shares of Encysive Pharmaceuticals Inc. (Businesswire)
05.03.08	Pfizer Presents New Opportunities for Global Growth (Businesswire)
28.02.08	Belden Appoints Mary S. McLeod of Pfizer Inc. to Board of Directors (PR Newswire)
06.02.08	Pfizer Presents New Data from HIV/AIDS Portfolio at Conference on Retroviruses and Opportunistic Infections (Businesswire)
23.01.08	Pfizer Reports Fourth-Quarter and Full-Year 2007 Results and 2008 Financial Guidance (Businesswire)
16.01.08	Adding Lipitor Early to Effective Blood Pressure Treatment Provided a Significant Reduction in Heart Attacks or Deaths from Heart Attacks over Five Years (Businesswire)
06.12.07	Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer (PR Newswire)
04.11.07	New Lipitor Data Analyses from Landmark Ideal and SPARCL Trials to Be Presented at Upcoming Annual Scientific Sessions of the American Heart Association (Businesswire)
29.10.07	Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM) (Businesswire)
25.10.07	Die Top-Jobs der Woche: Jetzt bewerben (Businesswire)
04.10.07	Dr. Martin Mackay Named President of Pfizer Global Research and Development (Businesswire)
03.10.07	Pfizer Hires New Vice President and Chief Talent Officer (Businesswire)
18.09.07	New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years (Businesswire)
27.08.07	Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program (PR Newswire)
14.08.07	Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders (Businesswire)
07.08.07	King Pharmaceuticals Reports Second-Quarter 2007 Financial Results (Businesswire)
06.08.07	Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009 (Businesswire)
06.08.07	Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA (Businesswire)
06.08.07	Seven Summits Research Releases Comments on WFC, VLO, PFE, UA and TIN (PR Newswire)
20.07.07	European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1 (PR Newswire)
18.07.07	Pfizer Announces First Occupant in its Science Incubator (Businesswire)
18.07.07	Pfizer Reports Second-Quarter 2007 Results, Reconfirms Full-Year 2007 and 2008 Financial Guidance and Updates Progress on Immediate Business Priorities (Businesswire)
16.07.07	Seven Summits Research Releases Comments on GE, PFE, INTC, WM and NE (PR Newswire)
30.06.07	Crystal-Studie bestätigt die wichtige Rolle, die Irinotecan bei der Behandlung von metastasierten Darmkrebs einnimmt (Businesswire)
23.06.07	Exubera Demonstrated Pulmonary Safety with Blood Sugar Control in Three-Year Interim Analyses (Businesswire)
11.06.07	King Pharmaceuticals Joins Together Rx Access(TM) To Help Americans Without Prescription Drug Coverage (Businesswire)
03.06.07	Patients Who Took Investigational Melanoma Compound CP-675,206 Showed Favorable Survival Outcomes, Pfizer Says (Businesswire)
29.05.07	Pfizer's Growing Strength in Oncology (Businesswire)
10.05.07	King Pharmaceuticals Reports First-Quarter 2007 Financial Results (Businesswire)
09.05.07	Icagen Reports First Quarter 2007 Financial Results (Businesswire)
02.05.07	Monogram Announces First Quarter 2007 Financial Results (PR Newswire)
26.04.07	Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds (PR Newswire)
20.04.07	Pfizer Delivers Solid First-Quarter 2007 Results, Updates Full-Year Expectations for 2007 and 2008 (Businesswire)
30.03.07	Icagen CEO P. Kay Wagoner Honored by Women in Bio (Businesswire)
26.03.07	Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis (Businesswire)
23.03.07	Pfizer to Present New Lipitor Data, Including Results from Three Large Atherosclerosis Imaging Trials, at the American College of Cardiology Meeting (Businesswire)
01.03.07	Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients (PR Newswire)
28.02.07	King Pharmaceuticals Reports Year-End and Fourth-Quarter 2006 Financial Results (Businesswire)
13.02.07	Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe (PR Newswire)
15.12.06	Icagen Announces Presentations Related to Senicapoc at the 2006 Annual Meeting of the American Society of Hematology (Businesswire)
01.12.06	Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

18:01		Starker Wochentag in New York: NASDAQ Composite liegt am Donnerstagmittag im Plus
18:01		Zuversicht in New York: S&P 500 mittags mit grünem Vorzeichen
18:01		NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit positivem Vorzeichen
17:58		LSE-Handel FTSE 100 notiert letztendlich im Minus
17:58		Schwacher Handel in Zürich: SMI zum Handelsende in Rot
17:58		Donnerstagshandel in Zürich: SPI sackt zum Ende des Donnerstagshandels ab
17:55		Roche-Aktie gewinnt: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
16:01		Freundlicher Handel: Dow Jones zum Handelsstart mit Zuschlägen

18:01

Starker Wochentag in New York: NASDAQ Composite liegt am Donnerstagmittag im Plus

18:01

Zuversicht in New York: S&P 500 mittags mit grünem Vorzeichen

18:01

NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit positivem Vorzeichen

17:58

LSE-Handel FTSE 100 notiert letztendlich im Minus

17:58

Schwacher Handel in Zürich: SMI zum Handelsende in Rot

17:58

Donnerstagshandel in Zürich: SPI sackt zum Ende des Donnerstagshandels ab

17:55

Roche-Aktie gewinnt: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt

16:01

Freundlicher Handel: Dow Jones zum Handelsstart mit Zuschlägen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	74.20	0.13 %	K V
Swiss Life Hldg	689.40	0.06 %	K V
Kuehne+Nagel Int	202.30	0.00 %	K V
Swisscom	501.50	-0.30 %	K V
Swiss Re	129.10	-0.39 %	K V
Logitech Intl	73.02	-2.41 %	K V
Roche Hldg G	246.70	-3.25 %	K V
UBS Group	26.89	-3.34 %	K V
Part Grp Hldg	1’217.00	-4.29 %	K V
ABB	48.73	-5.42 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten